- Home
- VRNA vs NNN Comparison
VRNA vs NNN Comparison
Compare VRNA & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- NNN
- Stock Information
- Founded
- VRNA 2005
- NNN 1984
- Country
- VRNA United Kingdom
- NNN United States
- Employees
- VRNA N/A
- NNN N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- NNN Real Estate Investment Trusts
- Sector
- VRNA Health Care
- NNN Real Estate
- Exchange
- VRNA Nasdaq
- NNN Nasdaq
- Market Cap
- VRNA 8.3B
- NNN 7.8B
- IPO Year
- VRNA 2017
- NNN N/A
- Fundamental
- Price
- VRNA $105.79
- NNN $42.10
- Analyst Decision
- VRNA Buy
- NNN Hold
- Analyst Count
- VRNA 11
- NNN 8
- Target Price
- VRNA $114.10
- NNN $43.86
- AVG Volume (30 Days)
- VRNA 1.4M
- NNN 1.4M
- Earning Date
- VRNA 08-06-2025
- NNN 08-05-2025
- Dividend Yield
- VRNA N/A
- NNN 5.70%
- EPS Growth
- VRNA N/A
- NNN N/A
- EPS
- VRNA N/A
- NNN 2.10
- Revenue
- VRNA $221,673,000.00
- NNN $894,702,000.00
- Revenue This Year
- VRNA $896.59
- NNN $4.51
- Revenue Next Year
- VRNA $77.56
- NNN $3.54
- P/E Ratio
- VRNA N/A
- NNN $20.07
- Revenue Growth
- VRNA N/A
- NNN 4.82
- 52 Week Low
- VRNA $24.50
- NNN $35.80
- 52 Week High
- VRNA $105.89
- NNN $49.57
- Technical
- Relative Strength Index (RSI)
- VRNA 68.01
- NNN 50.89
- Support Level
- VRNA $105.23
- NNN $41.82
- Resistance Level
- VRNA $105.81
- NNN $42.52
- Average True Range (ATR)
- VRNA 0.25
- NNN 0.55
- MACD
- VRNA -0.36
- NNN 0.11
- Stochastic Oscillator
- VRNA 87.88
- NNN 71.93
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About NNN NNN REIT Inc.
NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.